Jazz Pharmaceuticals

NASDAQ: JAZZ · Real-Time Price · USD
119.22
1.55 (1.32%)
At close: Aug 19, 2025, 3:59 PM
119.51
0.24%
Pre-market: Aug 20, 2025, 04:21 AM EDT

Jazz Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-404.84M 482.2M 560.12M 463.16M 394.92M 330.79M 414.83M 79.95M -86.51M -156.29M -224.06M -18.69M -51.87M -449.85M -329.67M -160.9M 40.16M 518.28M
Depreciation & Amortization
672.53M 661.56M 660.07M 650.85M 648.18M 644.72M 638.7M 624.23M 610.49M 607.12M 629.47M 649.36M 668.11M 659.22M 552.48M 459.54M 363.45M 283.85M
Stock-Based Compensation
262.1M 254.26M 248.04M 230.8M 227.15M 231.93M 226.84M 235.46M 236.02M 228.28M 222M 213.56M 210.12M 204.59M 189.01M 167.27M 144.39M 126.83M
Other Working Capital
-59M 133.12M -7.94M -44.98M -55.98M -13.3M -148.74M 66.99M 136.91M 139.93M 199.55M 36.83M 34.7M 18.84M 36.62M 62.13M 6.91M 45.4M
Other Non-Cash Items
1.07B 194.66M 215.94M 242.74M 235.22M 257.99M 276.29M 661.3M 843.11M 903.86M 882.12M 526.85M 421.9M 384.48M 345.44M 303M 221.65M 153.71M
Deferred Income Tax
-177.01M -185.78M -208.33M -241.87M -256.39M -260.54M -260.22M -369.69M -355.33M -312.97M -292.25M -174.27M -184.7M 42.97M 69.2M 80.56M 117.42M -92.07M
Change in Working Capital
-109.53M 151.57M -79.93M -181.01M -175.96M -166.36M -204.44M 35.4M 129.66M 68.92M 9.9M -133.84M -144.52M -138.92M -47.95M -62.45M -116.22M -78.92M
Operating Cash Flow
1.32B 1.56B 1.4B 1.16B 1.07B 1.04B 1.09B 1.27B 1.38B 1.38B 1.27B 1.11B 963.83M 702.49M 778.51M 787.02M 770.85M 911.68M
Capital Expenditures
-50.92M -70.05M -38.07M -34.88M -28.4M -27.04M -24.96M -399.24M -390.04M -465.72M -498.19M -123.78M -154.9M -80.66M -45.53M -75.68M -62.83M -161.34M
Cash Acquisitions
-858.05M n/a n/a 20M n/a n/a n/a -20M n/a 53M 53M -6.18B -6.18B -12.47B -12.45B -6.18B -6.17B 169.7M
Purchase of Investments
235M -535.05M -470M -120.1M -1.02B -765.1M -390.1M -208.96M -19.26M n/a n/a -61.16M -61.45M -6.12M -26.82M -762.62M -1.38B -2.23B
Sales Maturities Of Investments
1.43B 1.03B 845M 805M 470M 390M 270M 80M 60M 60M 60M 26.82M 26.82M 361.82M 1.12B 1.93B 2.29B 2.17B
Other Investing Acitivies
-1.54B -860.13M -845.13M -883.13M -28M -108M -99M -122.04M -142.34M -139.22M -163.22M 6.11B 6.09B -70.3M -66M -6.3B -6.29B -155.44M
Investing Cash Flow
-789.15M -405.22M -508.19M -213.11M -601.5M -430.14M -163.06M -589.24M -410.34M -413.76M -446.23M -131.94M -163.36M -5.99B -5.21B -5.13B -5.38B -210.46M
Debt Repayment
-367.48M -375.23M 374.77M 374.77M -31M -31M -31M -31M -331M -331M -582.01M -833.02M -1B 3.62B 3.87B 4.12B 4.57B 591.81M
Common Stock Repurchased
210.72M 49.3M n/a -460.52M -384.89M -319.06M -313.03M -216.04M -144.24M -54.99M -45.5M -48.69M -48.55M -45.59M -35.6M 116.93M 118.27M 114.17M
Dividend Paid
n/a n/a n/a -112.28M -112.28M -112.28M -112.28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
672.92M 36.85M 43.77M 455.44M 62.64M 61.3M 88.07M 4.75M 19.81M 42.53M 52.52M 37.33M 31.03M 60.99M 99.66M 151.73M 148.33M 110.83M
Financial Cash Flow
-699.84M -736.4M 20.52M -71.52M -396.44M -332.02M -305.25M -185.35M -395.91M -288.47M -529.49M -795.7M -971.82M 3.68B 3.97B 4.27B 4.72B 694.03M
Net Cash Flow
-165.92M 418.56M 906.55M 882.45M 73.5M 275.47M 624.83M 496.33M 571.04M 677.08M 290.03M 167.58M -180.13M -1.61B -466.32M -70.16M 105.32M 1.4B
Free Cash Flow
1.27B 1.49B 1.36B 1.13B 1.04B 1.01B 1.07B 867.4M 987.4M 917.98M 773.78M 983.98M 808.93M 621.83M 732.98M 711.34M 708.02M 750.33M